Pradaxa Lawsuits Pending in Federal Litigation Allege the Maker of the Blood Thinner Failed to Provide Adequate Warnings Regarding Pradaxa Bleeding Side Effects, Lack of Antidote to Reverse Hemorrhaging from The Drug.
The products liability litigation surrounding Pradaxa continues to grow, as Wright & Schulte LLC notes that the number of Pradaxa lawsuits pending in a federal multidistrict litigation underway in U.S. District Court, Southern District of Ohio has now exceeded 1,800. According to court documents, at least 1,844 claims have been filed in the Southern District of Ohio on behalf of 1,929 plaintiffs. All of the lawsuits allege that Boehringer Ingelheim, the manufacturer of the blood thinner, failed to provide adequate warnings regarding the potential for Pradaxa bleeding side effects, especially the lack of an effective antidote to reverse internal hemorrhaging that may occur with the drug. (In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation – MDL No. 2385)
Brought to market in 2010, Pradaxa is used to prevent strokes in people with atrial fibrillation. In October, the Institute for Safe Medicine Practices reported that the U.S. Food & Drug Administration (FDA) received just over 3,290 reports of Pradaxa side effects in 2012, more than any other drug it monitors. Most of the reports involved cases of Pradaxa bleeding, and more than 582 detailed fatalities among Pradaxa users.
(ismp.org/QuarterWatch/pdfs/2012Q4.pdf, ISMP QuarterWatch, October 17, 2013)
In its report, the ISMP was sharply critical of the FDA, which continues to maintain that Pradaxa is as safe as the decades-old blood thinner, warfarin. Both drugs can sometimes cause serious internal bleeding. However, administration of vitamin K can quickly bring an end to warfarin bleeding. The ISMP pointed out that while 18% of Pradaxa adverse events involved a fatality, only 6.5% of those attributed to warfarin reported a similar outcome.
According to court documents, the Pradaxa lawsuits currently pending in the Southern District of Illinois are moving forward quickly. The Court has scheduled a telephonic Status Conference for December 20, 2013. In an Order dated November 4th, the Court also set forth a procedure for selecting Pradaxa lawsuits for the litigation’s first bellwether trials. According to court documents, those trials are scheduled to begin in August 2014.
Wright & Schulte LLC is already representing plaintiffs in Pradaxa lawsuits that have been filed in the federal multidistrict litigation, and continues to offer free legal consultations to alleged victims of Pradaxa bleeding side effects. For more information on filing a Pradaxa bleeding lawsuit, or to arrange for a free legal consultation, please visit yourlegalhelp.com.
About Wright & Schulte LLC
Wright & Schulte LLC, an experienced personal injury firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright & Schulte LLC stand up for the rights of people who have been injured or wronged and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you’re looking for a law firm that will guarantee the aggressive and personal representation you deserve, please do not hesitate to contact Wright & Schulte LLC today. Free Pradaxa lawsuit case evaluations are available through yourlegalhelp.com or by calling 1-800-399-0795.
Wright & Schulte LLC
865 S. Dixie Dr.
Vandalia, Ohio 45377